Figure 6.

Antibody binding to Daudi cells with two increasing concentrations and a dissociation measured in plain medium (red) evaluated by applying a global fit (black) (a, b) FITC-labeled OFA at 12 and 36 nM during the association phase (n = 3) fitted to the bivalent model (a) or the 1:2 model (b). (c, d) FITC-labeled RTX at 20 and 60 nM during the association phase (n = 4) fitted to the bivalent model (c) or the 1:2 model (d). (e, f) FITC-labeled OBI at 12 and 36 nM during the association phase (n = 3), fitted to the bivalent model (e) or the 1:2 model (f).